… We propose IL-17A as a silent amplifier of the COVID-19 immune response and (… of
Coronavirus disease 2019 (COVID-19) signs and symptoms, the physiopathology of COVID-19 is still …

… initial stages of COVID-19. Furthermore, the benefits of targeted Th17 cell and IL-17 therapy
… regarding the pathological role of IL-17 in COVID-19 is needed and randomized controlled …

… Results: We report that IL-17A increases in COVID-19 subjects irrespective of disease … ), p<
0.00001] as well as higher in patients with severe COVID-19 [WMD= 4.13 pg/ml (95% CI: 1.65…

… COVID-19 [Citation16]. It has already been shown that Th17 count and IL-17 levels were
increased in critically ill COVID-19 … Treg cells, RORγt/FoxP3, and IL‐17/IL‐10 were considerably …

… for anti-inflammatory drugs for COVID-19 patients presenting with CRS. This article
provides the proposed immunopathological mechanism of IL-17A/F and drugs against IL-17–IL-17R …

… interleukin (IL)-17A level as a prognostic marker in COVID-19… The results of this study suggest
that IL-17A, an important … COVID-19, may also help predict mortality in COVID-19 patients. …

… salivary IL-17A … IL-17A, TNFα, IL-1β protein levels in saliva of COVID-19 patients with
different severities, and found that among these cytokines, IL-17A was associated with COVID-19 …

… COVID-19 patients, IL-17A could potentially promote a pro-thrombotic state in the vascular
system. Indeed, the increased level of this cytokine in COVID-19 … to characterize IL-17 levels …

… interleukin 17A (IL-17A) as it induces stronger and broader human IL-17 receptor (hIL-17R)
signaling than IL-17A. … of the IL-17 cytokine contributes to COVID-19 severe inflammation. …

… review discusses the roles of IL-17 and Th17 responses in the pathophysiology of COVID-…
of IL-17A, its relevance to COVID-19, and the potential for IL-17A-based therapeutics. …